Cart
sales@molnova.com
GRK5-IN-2
CAS No. 1642839-27-7
GRK5-IN-2( —— )
Catalog No. M28800 CAS No. 1642839-27-7
GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 68 | Get Quote |
|
| 10MG | 110 | Get Quote |
|
| 25MG | 222 | Get Quote |
|
| 50MG | 357 | Get Quote |
|
| 100MG | 530 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGRK5-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionGRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
-
DescriptionGRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetGRK (GPCRK)
-
RecptorNPY Y2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1642839-27-7
-
Formula Weight380.4
-
Molecular FormulaC20H20N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (164.30 mM)
-
SMILESCn1c(-c2ccco2)nc2c1cc(Nc(cc1OC)cc(OC)c1OC)nc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Domin H, et al. Characterization of the Brain Penetrant Neuropeptide Y Y2 Receptor Antagonist SF-11. ACS Chem Neurosci. 2019;10(8):3454-3463.
molnova catalog
related products
-
PEN (human)
Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.
-
CCG-215022
CCG-215022 (CCG215022) is a potent and selective pan GRK inhibitor with IC50 of 0.15/0.38/3.9 uM for GRK2/5/1 respectively.
-
GSK-180736A
A highly selective and potent GRK2 inhibitor with IC50 of 0.77 uM.
